(RTTNews) - Roche (RHHBY) said Monday that it has received 510(k) clearance from the U.S. Food and Drug Administration for its highly-sensitive in-situ hybridisation (ISH) test, the VENTANA Kappa ...

The test is carried out on Roche’s cobas e analysers, which are widely used around the world and are also used to detect SARS-CoV-2 – the virus that causes COVID-19 – from patient swabs.

Although many people recover quickly from COVID-19, the disease caused by the coronavirus known as SARS-CoV-2, others may experience symptoms for months. Researchers are still determining the cause of ...

Facing a health emergency that echoes the distressing days of the Covid-19 pandemic, China is grappling with a new challenge as it battles the spread of multiple viruses, including the human ...

WHO Director-General Dr. Tedros Adhanom Ghebreyesus made the announcement during a press conference in Geneva, following a meeting of the organization’s emergency committee on Thursday. The decision ...

Thomas Roche, 27, was last seen at 12:30 BST on 6 October when he left the flat he shared with his girlfriend in Chester Close, Bletchley, Buckinghamshire, for a cigarette. His sister Carly Roche ...

Australia will have the chance to defend their World Test Championship crown, claiming victory over India in the fifth and final Border-Gavaskar Test to secure their place in the Final at Lord's in ...

Roche share price performance has been flattish of late, but that's good for some relative outperformance as the pharmaceutical sector has underperformed. Roche has seen further clinical setbacks ...

But a negative COVID-19 test is not great at completely ruling out a SARS-CoV-2 infection because the test has a high false negative rate. That’s because it is not easy to get a good saliva ...

Neighbouring regions are actively monitoring the virus spread. As respiratory illnesses alarmingly increase in China, there are complaints of congested hospitals and overburdened healthcare ...

The COVID-19 pandemic was five years ago but the virus continues to circulate among global populations—could that change in 2025? The experts think not. In fact, three experts told Newsweek that ...